TearScience
Recent Finacing
Equity
Recent Raise
$70M
TearScience develops in-office diagnostic and therapeutic ophthalmic devices—LipiView interferometer measuring tear film lipid thickness and LipiFlow thermal pulsation to treat Meibomian Gland Dysfunction—for eye care providers.
Highlights
Focus Areas
Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
Recent Investors
Financials
$114.5M
Total Raised
2
Funding rounds
7
Investors